|Bid||0.5750 x 1000000|
|Ask||0.5900 x 682300|
|Day's range||0.5600 - 0.6300|
|52-week range||0.3600 - 0.9850|
|Beta (5Y monthly)||1.73|
|PE ratio (TTM)||N/A|
|Earnings date||28 Aug 2023 - 01 Sept 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Highlights Archer Materials has advanced the room temperature capabilities of its qubit material, achieving unprecedented quantum coherence times.The long coherence times increases the time-window for processing quantum information at room temperature beyond that for any known, similar qubit materials.This milestone, which was previously only achieved at -173°C, means more complex computing applications could potentially be performed in more normal operating environments.Archer is the only ASX l
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Highlights Archer Materials is the first Australian company to partner with the World Economic Forum’s Centre for the Fourth Industrial Revolution (C4IR)Recognises Archer’s leadership and innovation in qubit processors for semiconductor devices in quantum computing, and graphene-based biochip devices in medical diagnosticsProvides direct access for collaborators to utilise the Company’s semiconductor technology, strategic partnerships for product development, and to bolster R&DComplements Archer
Image 1 An Archer 4 x 4 mm single-chip quantum electronic device after installing and bonding into a commercial chip carrier. This completed device is compatible with measurement setups for electronic characterisation at cryogenic temperatures as well as ambient conditions at room temperature using Archer’s in-house lab capabilities as well as external facilities. Highlights 12CQ chip development advances to wafer-scale quantum electronic device fabrication using foundry-compatible UV optical an
Archer's biochip in action Archer's biochip in action Highlights Archer has advanced its biochip development by overcoming a conventional limitation preventing many biosensing platforms from becoming broadly useful.The work builds on the significant technology development by the Company to potentially allow for the selective, complex on-chip detection of target biomolecules.Archer has developed software and incorporated hardware with its biochip platform that addresses a fundamental phenomenon t
While Archer Materials Limited ( ASX:AXE ) shareholders are probably generally happy, the stock hasn't had particularly...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...